Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine
- PMID: 2279740
- PMCID: PMC1384878
Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine
Abstract
Peritoneal macrophages from CBA mice incubated with recombinant murine tumour necrosis factor (TNF-alpha) are effective in killing the protozoa parasite Leishmania major in vitro. The leishmanicidal activity is directly correlated with the level of nitrite (NO2-) in the culture supernatants. The killing of intracellular parasites can be completely inhibited by L-NG-monomethyl arginine (L-NMMA), a specific inhibitor of the L-arginine:nitric oxide (NO) pathway. The level of NO2-, which is also a measurement of NO production, in the culture supernatant of TNF-alpha-activated macrophages can be progressively decreased to basal level with increasing concentrations of L-NMMA, but not with its D-enantiomer, D-NMMA. These data demonstrate that NO is an important effector mechanism in the TNF-alpha-induced macrophage killing of intracellular protozoa.
Similar articles
-
Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.J Immunol. 1990 Jun 15;144(12):4794-7. J Immunol. 1990. PMID: 2351828
-
Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.J Immunol. 1990 Dec 15;145(12):4306-10. J Immunol. 1990. PMID: 2175327
-
Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.J Immunol. 1990 Dec 15;145(12):4290-7. J Immunol. 1990. PMID: 2124240
-
Biosynthesis and actions of nitric oxide.Semin Perinatol. 1991 Feb;15(1):16-9. Semin Perinatol. 1991. PMID: 2063225 Review. No abstract available.
-
Macrophage nitric oxide mediates immunosuppression in infectious inflammation.Immunobiology. 1994 Oct;191(4-5):493-502. doi: 10.1016/S0171-2985(11)80455-9. Immunobiology. 1994. PMID: 7713563 Review.
Cited by
-
Immunobiology of experimental leishmaniasis.Med Microbiol Immunol. 1992;181(1):1-12. doi: 10.1007/BF00193391. Med Microbiol Immunol. 1992. PMID: 1349724 Review.
-
Ageing impairs protective immunity and promotes susceptibility to murine visceral leishmaniasis.Parasitology. 2022 Aug;149(9):1249-1256. doi: 10.1017/S0031182022000828. Epub 2022 Jun 7. Parasitology. 2022. PMID: 35670372 Free PMC article.
-
Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.Clin Exp Immunol. 2016 Aug;185(2):165-79. doi: 10.1111/cei.12780. Epub 2016 Apr 27. Clin Exp Immunol. 2016. PMID: 26898994 Free PMC article.
-
Alcoholic Fractions F5 and F6 from Withania somnifera Leaves Show a Potent Antileishmanial and Immunomodulatory Activities to Control Experimental Visceral Leishmaniasis.Front Med (Lausanne). 2017 May 12;4:55. doi: 10.3389/fmed.2017.00055. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28553635 Free PMC article.
-
Leishmania Immunity: Advancing Immunotherapy and Vaccine Development.Microorganisms. 2020 Aug 7;8(8):1201. doi: 10.3390/microorganisms8081201. Microorganisms. 2020. PMID: 32784615 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical